April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy
Author Affiliations & Notes
  • Weiye Li
    Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania
    Tongji Eye Institute and Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, China
  • Xia Lei
    Tongji Eye Institute and Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, China
    Institute of Health Sciences (IHS), SIBS, CAS & SJTUSM, Shanghai, China
  • Bo Ma
    Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China
  • Yu Zhang
    Department of Ophthalmology, Huashan Hospital Affiliated to Fudan University, S, China
  • Yan Yan
    Department of Ophthalmology, Ruijin Hospital Affiliated to SJTUSM, Shanghai, China
  • Guo-Tong Xu
    Tongji Eye Institute and Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, China
    Institute of Health Sciences (IHS), SIBS, CAS & SJTUSM, Shanghai, China
  • Footnotes
    Commercial Relationships  Weiye Li, None; Xia Lei, None; Bo Ma, None; Yu Zhang, None; Yan Yan, None; Guo-Tong Xu, None
  • Footnotes
    Support  Supported by Sciences and Technology Commission of Shanghai Municipality (#08410701200) and Unrestricted Research Fund from the Clear Vision Foundation, Philadelphia USA.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3170. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Weiye Li, Xia Lei, Bo Ma, Yu Zhang, Yan Yan, Guo-Tong Xu; Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3170.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the involvement of erythropoietin (EPO)/erythropoietin receptor (EPOR) system in neovascularization and vascular regeneration in diabetic retinopathy (DR).

Methods: : EPOR positive circulating progenitor cells (CPCs: CD34+) and endothelial progenitor cells (EPCs: CD34+KDR+) were assessed in type 2 diabetic patients with different stages of DR by flow cytometry. This cohort consisted of seven age- and sex-matched patients (control), seven with non-proliferative DR (NPDR), eight with active proliferative DR (PDR), and seven with active PDR as well as diabetic nephropathy (PDR-DN).

Results: : Both the number of EPOR+ CPCs or EPOR+ EPCs and the proportion of these cells in CPCs or EPCs were reduced remarkably in NPDR, whereas, they were rebounded in active PDR and PDR-DN.

Conclusions: : These findings suggest that exogenous EPO, mediated via the EPO/EPOR system of EPCs, may alleviate the impaired vascular regeneration in NPDR, whereas it might aggravate retinal neovascularization due to a rebound of EPOR+ EPCs associated with ischemia in PDR.

Keywords: diabetic retinopathy • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×